FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Create a free account to read 3 full reports each month — plus a 14-day Pro trial. Get started →

Travelers Cos.

TRVFinancials

Generated Sep 5, 2026, 01:36 PM UTC

analytical score 7

TRV (Travelers Cos.) analytical snapshot. Revenue grew +5.2% YoY to $48.83B. 5-year revenue CAGR +7.0%; 10y CAGR +6.5%. Net margin at 12.88% (expanding ▲). Market cap $77.04B at $369.35 per share. Trailing P/E 13.47, P/S 1.58, P/B 2.33. EV/Operating income ≈ 22.60 (EV $82.28B). Risk: Moderate. Macro: Risk-on · Supportive. Composite analytical score 7 (data confidence 74%). Descriptive analytics from public filings — not investment advice.

Market cap
$77.04B
208.58M shares
Price
$369.35
NYQ
P/E (ttm)
13.47
Revenue (FY)
$48.83B
YoY +5.2%
Net margin
12.88%
▲ 5.17pp
Free cash flow
Risk level
Moderate

Free SEC analysis

— computed from SEC filings, free to read
Free previewRegulatory Analyst

Filings & Ownership

Regulatory Analyst
score -10Stable
80% conf

Latest annual report (10-K) filed Feb 12, 2026. Latest quarterly report (10-Q) filed Jul 17, 2026. 8 recent 8-K material-event filings in the index.

  • Latest annual report (10-K) filed Feb 12, 2026.
  • Latest quarterly report (10-Q) filed Jul 17, 2026.
  • 8 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 5 sell transactions — net selling $9.0M.
  • ~10,000+ recent 13F-HR filings reference Travelers Cos.; broad institutional reporting.
  • Recent filers include Rosenbaum Jay D., Rosenbaum Jay D., Rosenbaum Jay D..
  • 20 recent 13G passive institutional ownership notices.
Latest 10-K
Feb 12, 2026
Annual report
Latest 10-Q
Jul 17, 2026
8-K (recent)
8
Insider net
-$9.0M
0B/5S
13F filers
10k+
Activist 13D
0
Recent 13F institutional filers (SEC EDGAR full-text)
FilerFormFiled
Rosenbaum Jay D.13F-HROct 26, 2021
Rosenbaum Jay D.13F-HRJul 14, 2021
Rosenbaum Jay D.13F-HRApr 26, 2021
Connolly Sarah T.13F-HRJul 14, 2021
Connolly Sarah T.13F-HRApr 26, 2021
Recent insider Form 4 activity
InsiderDateNetBuys/Sells
OLIVO MARIAAug 31, 2026-$2.2M0/1
Yin Daniel Tei-HwaJul 27, 2026-$2.8M0/1
Kurtzman DianeJul 27, 2026-$1.6M0/1
Rowland David DonnayJul 24, 2026-$1.9M0/1
Munson Paul E.Jul 24, 2026-$564.1K0/1
Recent 8-K material events
DateFormDescription
Aug 7, 20268-KFORM 8-K
Jul 24, 20268-K8-K
Jul 17, 20268-K8-K
May 22, 20268-KFORM 8-K
May 21, 20268-KFORM 8-K
Apr 16, 20268-K8-K
Feb 17, 20268-KFORM 8-K
Feb 6, 20268-KFORM 8-K
Insider Form 4 sentiment (transactions)
Buys: 0
Sells: 5
Buys
Sells
Free previewSEC Filing Analyst

SEC Filing Deep-Analysis

SEC Filing Analyst
score -46Deteriorating
62% conf

3 risk signal(s), 1 positive signal(s), 1 watch item(s) detected from XBRL filing diff analysis. 3 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.

  • NEW: Going concern doubt in latest filing: The term "going concern" "substantial doubt" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 4 filing(s).
  • NEW: Substantial doubt about ability to continue in latest filing: The term "substantial doubt" "ability to continue" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 4 filing(s).
  • Restatement of financial statements: The term "restatement of" "previously issued" appears in 5 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
  • Operating cash flow exceeds net income: OCF is 1.69x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • NEW: Impairment charge: Impairment charge appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • Endogenous analysis: 3 risk signal(s) detected versus 1 positive signal(s). The balance of evidence suggests elevated filing-specific risk that warrants monitoring in subsequent filings.
  • 5 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 3 new risk-language term(s) detected in filing text: Going concern doubt, Substantial doubt about ability to continue, Impairment charge.
  • Ongoing high-severity risk language: Restatement of financial statements.
Revenue
$48.83B
+5.2% YoY
Operating income
$3.64B
+2.1% YoY
Net income
$6.29B
+25.8% YoY
Operating cash flow
$10.61B
+16.9% YoY
Total assets
$143.71B
+7.9% YoY
Total liabilities
$110.81B
+5.2% YoY
Long-term debt
$5.86B
-6.4% YoY
Cash & equivalents
$842.0M
+20.5% YoY
Filing quality score
75/100
5 new disclosures
SEC XBRL metric changes (latest annual vs prior)
MetricPrior yearLatest yearChange% Change
Revenue$46.42B$48.83B$2.40B+5.2%
Operating income$3.57B$3.64B$74.0M+2.1%
Net income$5.00B$6.29B$1.29B+25.8%
Operating cash flow$9.07B$10.61B$1.53B+16.9%
Total assets$133.19B$143.71B$10.52B+7.9%
Total liabilities$105.33B$110.81B$5.49B+5.2%
Long-term debt$6.26B$5.86B$-400.0M-6.4%
Cash & equivalents$699.0M$842.0M$143.0M+20.5%
Stockholders equity$27.86B$32.89B$5.03B+18.1%
SG&A expense$5.82B$6.12B$301.0M+5.2%
Interest expense$392.0M$425.0M$33.0M+8.4%
XBRL disclosure changes (new vs dropped concepts)
TypeConcepts
AddedAlternativeInvestment, DisposalGroupIncludingDiscontinuedOperationInvestment, InvestmentsFairValueDisclosure, ProceedsFromDivestitureOfBusinesses, RepaymentsOfDebt
RemovedAccruedIncomeTaxesCurrent, AmortizationOfIntangibleAssets, AssetsHeldByInsuranceRegulators, AssumedPremiumsEarned, AssumedPremiumsWritten, AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost, AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue, AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost, AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue, AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
Risk language in filing text (EDGAR full-text search)
TermSeverityRecentPriorStatus
Going concern doubthigh40NEW
Substantial doubt about ability to continuehigh40NEW
Restatement of financial statementshigh51Ongoing
Impairment chargemedium50NEW
Restructuringmedium53Ongoing
Off-balance sheet arrangementsmedium52Ongoing
Related party transactionslow50NEW
Filing signal breakdown
Red flags: 3
Positive: 1
Watch: 1
Red flags
Positive
Watch
Free previewFundamentals Analyst

Fundamentals

Fundamentals Analyst
score 45Improving
60% conf

Revenue grew +5.2% YoY to $48.83B. 5-year revenue CAGR +7.0%; 10y CAGR +6.5%. Net margin at 12.88% (expanding ▲).

  • Revenue grew +5.2% YoY to $48.83B.
  • 5-year revenue CAGR +7.0%; 10y CAGR +6.5%.
  • Net margin at 12.88% (expanding ▲).
  • Return on equity 19.12%, ROA 4.38%, ROIC 0.00%.
  • Gross margin 0.00%, operating margin 0.00%.
  • Net income up ▲ +25.8% YoY.
  • Debt/equity 0.18, current ratio —, net debt $5.24B.
  • Asset turnover 0.34 — capital efficiency.
Revenue (FY)
$48.83B
YoY +5.2%
Net margin
12.88%
▲ 5.17pp
ROE
19.12%
ROA 4.38%
ROIC
0.00%
EPS (diluted)
$27.43
FY2025
Free cash flow
Debt / equity
0.18
Cash $621.0M
Current ratio
Equity $33.12B
Annual fundamentals — up to 10 years (SEC 10-K, US-GAAP)
FYRevenueRev YoYGross%Op%Net%FCFROE%
2024$46.42B+12.2%0.000.0010.7717.94
2025$48.83B+5.2%0.000.0012.8819.12
Quarterly revenue trend (last 6 quarters, SEC 10-Q)
Quarter endRevenueYoYQoQNet margin
Sep 30, 2024$11.90B+11.9%10.58%
Mar 31, 2025$11.81B+5.2%-0.8%3.34%
Jun 30, 2025$12.12B+7.4%+2.6%12.45%
Sep 30, 2025$12.47B+4.8%+2.9%15.14%
Mar 31, 2026$11.92B+1.0%-4.4%14.35%
Jun 30, 2026$12.15B+0.3%+1.9%18.17%
+8 more years of history, charts & full breakdown Pro

Pro analysis — preview

— score, signals & key metrics shown; full reasoning locked

Valuation

Valuation Analyst
score 0Stable
83% conf

Market cap $77.04B at $369.35 per share. Trailing P/E 13.47, P/S 1.58, P/B 2.33. EV/Operating income ≈ 22.60 (EV $82.28B).

  • Market cap $77.04B at $369.35 per share.
Market cap
$77.04B
208.58M shares
P/E (ttm)
13.47
P/S
1.58
P/B
2.33
EV
$82.28B
Intrinsic (DCF)
ProFull breakdown & reasoning locked

Price & Technicals

Technical Analyst
score 25Improving
85% conf

Price $369.35 — uptrend (above 200-DMA); 1-month momentum negative. RSI(14) 55.33.

  • Price $369.35 — uptrend (above 200-DMA); 1-month momentum negative.
Price
$369.35
NYQ
RSI(14)
55.33
50-DMA
$363.14
200-DMA
$312.42
Volatility (ann.)
20.69%
52w range
$252.26–$398.70
-7.4% from high
ProFull breakdown & reasoning locked

Macro & Rates

Macro Analyst
score 30Improving
80% conf

Risk-on · Supportive. Real GDP growth 1.50% (quarterly, as of Apr 1, 2026). CPI inflation +3.3% YoY. Fed funds rate 3.63%, 10Y Treasury 4.77%.

  • Market regime: Risk-on · Supportive.
GDP growth
1.50%
CPI (YoY)
+3.3%
Fed funds
3.63%
10Y yield
4.77%
10Y−2Y
0.41pp
Unemployment
4.10%
ProFull breakdown & reasoning locked

Risk Scorecard

Risk Analyst
score -6Stable
83% conf

Composite risk Moderate. Leverage debt/equity 0.18 (low). Earnings stability: net-margin stdev 2.70pp over 18y.

  • Composite risk: Moderate.
Risk level
Moderate
Debt / equity
0.18
Current ratio
Margin stdev
2.70pp
Cash / assets
0.43%
Liab / assets
76.93%
ProFull breakdown & reasoning locked

See the full picture behind every stock

Unlock the complete 10-year fundamentals, DCF & Graham intrinsic value, 13F/13D ownership flow, risk scorecard, multi-analyst bull/bear debate — plus watchlist alerts and your research workspace. Start with a 14-day Pro trial.

3 sections free · 4 Pro previews · composite 7

Macro exposure

Rate-sensitive · High sensitivity
Neutral

Macro regime: Risk-on · Supportive. Travelers Cos. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.

Macro regime
Risk-on · Supportive
Yield curve
Normal
VIX
14.32
Fed funds
3.63%
CPI YoY
+3.3%

Analytical read

deterministic preview

Revenue grew **+5.2%** YoY to $48.83B..

Risk
Moderate
Macro regime
Risk-on · Supportive
Macro exposure
Neutral
Descriptive analytics from public filings and macro data — not investment advice.

Peer comparison

Rate-sensitive group

How TRV stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.

CompanyScoreMacro
CME Group Inc. CME32Neutral
Allstate Corp. ALL28Neutral
Mastercard Inc. MA27Neutral
Visa Inc. V24Neutral
Charles Schwab Corp. SCHW19Neutral
Capital One Financial COF19Neutral
Digital Realty Trust DLR11Neutral
U.S. Bancorp USB10Neutral
Simon Property Group SPG10Neutral
Chubb Ltd. CB8Neutral
Dominion Energy D8Neutral
Travelers Cos. TRV● you7Neutral
MetLife Inc. MET7Neutral
American Express Co. AXP5Neutral
Moody's Corp. MCO5Neutral
Welltower Inc. WELL5Neutral
JPMorgan Chase & Co. JPM4Neutral
Wells Fargo & Co. WFC1Neutral
PNC Financial Services PNC1Neutral
Truist Financial TFC1Neutral
Bank of America Corp. BAC0Neutral
Bank of New York Mellon BK0Neutral
Marsh & McLennan MMC0Neutral
Equity Residential EQR0Neutral
Citigroup Inc. C-2Neutral
BlackRock Inc. BLK-2Neutral
Prologis Inc. PLD-2Neutral
Goldman Sachs Group GS-4Neutral
American Tower Corp. AMT-4Neutral
S&P Global SPGI-5Neutral
American Water Works AWK-8Neutral
Public Storage PSA-9Neutral
American Electric Power AEP-9Neutral
Equinix Inc. EQIX-10Neutral
Morgan Stanley MS-11Neutral
Realty Income Corp. O-12Neutral
NextEra Energy NEE-13Neutral
Duke Energy Corp. DUK-14Neutral
Xcel Energy XEL-17Neutral
Southern Company SO-17Neutral
Exelon Corp. EXC-19Neutral
Crown Castle Inc. CCI-21Neutral
American International Group AIG-23Neutral